Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have agreed to take part and signed a consent form.
- People diagnosed with a specific type of colon cancer (colon adenocarcinoma) that is either high-risk Stage III or Stage IV.
- People whose treatment plan includes a chemotherapy drug called oxaliplatin, whether the cancer has spread or not.
- People who are generally well enough to carry out daily activities with little to no limitation (confirm with trial site for exact fitness level required).
Who may not be able to join:
- People who already have nerve damage or nerve-related problems before the trial begins.
- People with diabetes that is not well managed or controlled.
- People with a known allergy to gloves (confirm with trial site regarding which materials are relevant).
- People who have previously been treated with the chemotherapy drugs paclitaxel, docetaxel, or oxaliplatin.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bruna Catin Kupper, Nurse, PhD, AC Camarco Cancer Center
Phone: +55 (11) 2189-5000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Oxaliplatin-Induced Peripheral Neuropathy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.